The Technical Analyst
NeuroOne Medical [NMTC]
Exchange: PNK Industry: Medical Devices
NeuroOne Medical Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.50% $1.170
America/New_York / 3 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 30.34 mill |
| EPS: | -0.680 |
| P/E: | -1.720 |
| Earnings Date: | May 09, 2024 |
| SharesOutstanding: | 25.93 mill |
| Avg Daily Volume: | 0.196 mill |
| RATING 2024-05-03 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.720 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -1.720 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-1.033 (-188.26%) $-2.20 |
| Date: 2024-05-03 |
| Expected Trading Range (DAY) |
|---|
|
$ 1.060 - 1.280 ( +/- 9.40%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-30 | Mertens Steve | Sell | 252 | Common Stock |
| 2024-04-30 | Christianson Mark | Sell | 90 | Common Stock |
| 2024-04-30 | Rosa David A | Sell | 2 239 | Common Stock |
| 2024-04-21 | Mertens Steve | Sell | 7 250 | Common Stock |
| 2024-04-21 | Christianson Mark | Sell | 2 030 | Common Stock |
| INSIDER POWER |
|---|
| 85.22 |
| Last 99 transactions |
| Buy: 2 791 460 | Sell: 229 947 |
Forecast:
16:00 - $1.180
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.180
Forecast 2: 16:00 - $1.180
Forecast 3: 16:00 - $1.180
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.170 (-2.50% ) |
| Volume | 0.0409 mill |
| Avg. Vol. | 0.196 mill |
| % of Avg. Vol | 20.86 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NMTC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NMTC
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
Latest Press Releases
2024-04-10 09:00:00 - Press Release
Neuroone® Ceo Dave Rosa Featured On Bloomberg Technology
Eden prairie, minn., april 10, 2024 (globe newswire) -- neuroone medical technologies corporation (nasdaq: nmtc) (“neuroone” or the “company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by chief executive officer dave rosa on bloomberg television's bloomberg technology. a replay of the segment, which aired live yesterday, can be viewed at neuroone-bloomberg.
2024-04-09 09:05:00 - Press Release
Neuroone® Announces First Implant Of Onerf™ Ablation Electrodes
First to market fda-cleared thin-film, seeg-guided rf system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control
2024-04-04 09:00:00 - Press Release
Neuroone® Ceo Dave Rosa Featured On Fox Business Network's Varney & Co.
Eden prairie, minn., april 04, 2024 (globe newswire) -- neuroone medical technologies corporation (nasdaq: nmtc) (“neuroone” or the “company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by chief executive officer dave rosa on fox business network's varney & co. on wednesday april 3rd. the segment, which aired live yesterday, can be viewed online at fox business .
2024-03-26 09:00:00 - Press Release
Neuroone® Initiates Limited Commercial Launch Of Onerf™ Ablation System
First to market fda-cleared thin-film, seeg-guided rf system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control
2024-03-08 12:00:00 - Press Release
Neuroone® To Participate In The 36th Annual Roth Conference
Eden prairie, minn., march 08, 2024 (globe newswire) -- neuroone medical technologies corporation (nasdaq: nmtc) ("neuroone" or the "company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its participation in the 36th annual roth conference being held march 17-19, 2024 in dana point, california. chief executive offer dave rosa and chief financial officer ron mcclurg will host one-on-one meetings with institutional investors and analysts on monday, march 18th and tuesday, march 19th.
Latest News
2024-02-13 20:04:04 - Seeking Alpha
NeuroOne Medical Technologies Corporation (NMTC) Q1 2024 Earnings Call Transcript
2024-02-08 15:30:00 - GlobeNewsWire
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on February 13, 2024 at 4:30 PM Eastern Time to discuss financial results for its first quarter of fiscal year 2024 ended December 31, 2023, and provide a corporate update.
2023-10-13 09:30:00 - GlobeNewsWire
NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023
EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that CFO Ron McClurg will present at the ThinkEquity Conference in New York on Thursday, October 19, 2023.
2023-09-06 16:00:00 - GlobeNewsWire
NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference
EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced its upcoming virtual presentation at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023.
2023-08-14 19:26:05 - Seeking Alpha
NeuroOne Medical Technologies Corporation (NMTC) Q3 2023 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2023 Results Conference Call August 14, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Operator Good day, ladies and gentlemen. Thank you for standing by.
2023-05-12 20:48:04 - Seeking Alpha
NeuroOne Medical Technologies Corporation (NMTC) Q2 2023 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation Second Quarter Fiscal Year 2023 Financial Results Conference Call.
2023-05-11 12:17:00 - GlobeNewsWire
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal second quarter 2023 ended March 31, 2023 and provide a corporate update on May 11, 2023 at 4:30 PM Eastern Time.
2023-05-05 09:00:00 - GlobeNewsWire
NeuroOne® to Present at the Sidoti Micro-Cap Virtual Conference on May 10
EDEN PRAIRIE, Minn., May 05, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that CFO Ron McClurg will present at the Sidoti Micro-Cap Virtual Conference being held May 10-11, 2023.
2023-02-14 18:09:04 - Seeking Alpha
NeuroOne Medical Technologies Corporation (NMTC) Q1 2023 Earnings Call Transcript
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q1 2023 Earnings Conference Call February 14, 2023 4:30 AM ET Company Participants Dave Rosa - President and CEO Ron McClurg - CFO Conference Call Participants Alex Nowak - Craig Hallum Capital Group Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation First Quarter Fiscal Year 2023 Financial Results Conference Call.
2022-12-08 09:00:00 - PRNewsWire
NeuroOne® to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide Corporate Update on December 13
EDEN PRAIRIE, Minn. , Dec. 8, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal fourth quarter and full fiscal year ended September 30, 2022, and provide a corporate update, on December 13, 2022 at 4:30 PM Eastern Time.